In various tumor cells such as ovarian cancer, lung cancer, and rectal cancer, the PRSS22 expression is higher than the corresponding normal cells, suggesting that its abnormal expression may be related to the occurrence and development of tumors (19, 20). Here, PRSS22 is linked to lung cancer.